Powder: -20°C for 3 years | In solvent: -80°C for 1 year
SARS-CoV-2-IN-39 is a SARS-CoV-2 inhibitor with an EC50 of 1 μM. SARS-CoV-2-IN-39 has antiviral activity and inhibits SARS-CoV-2 by inhibiting SKP2 protein and stabilizing BECN1.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 52.00 | |
5 mg | In stock | $ 119.00 | |
10 mg | In stock | $ 175.00 | |
25 mg | In stock | $ 295.00 | |
50 mg | In stock | $ 443.00 | |
100 mg | In stock | $ 653.00 | |
500 mg | In stock | $ 1,390.00 |
Description | SARS-CoV-2-IN-39 is a SARS-CoV-2 inhibitor with an EC50 of 1 μM. SARS-CoV-2-IN-39 has antiviral activity and inhibits SARS-CoV-2 by inhibiting SKP2 protein and stabilizing BECN1. |
Targets&IC50 | SARS-CoV-2:1 μM(EC50) |
Molecular Weight | 349.66 |
Formula | C14H8ClF4NO3 |
CAS No. | 2882823-03-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
SARS-CoV-2-IN-39 2882823-03-0 Immunology/Inflammation Microbiology/Virology Antiviral SARS-CoV SARSCoV2IN39 inhibitor inhibit